Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis
A lot of data suggests endocrine gland-derived vascular endothelial growth factor (EG-VEGF) to be restricted to endocrine glands and to some endocrine-dependent organs. Many evidences show that EG-VEGF stimulates angiogenesis and cell proliferation, although it is not a member of the VEGF family. At...
Saved in:
Main Authors: | Ana Silvia Corlan, Anca Maria Cîmpean, Adriana-Andreea Jitariu, Eugen Melnic, Marius Raica |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2017/3232905 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
by: Toshiaki Kubota, et al.
Published: (2012-01-01) -
Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing
by: Gopi Krishna Kolluru, et al.
Published: (2012-01-01) -
YAP Overexpression in Breast Cancer Cells Promotes Angiogenesis through Activating YAP Signaling in Vascular Endothelial Cells
by: Yu Yan, et al.
Published: (2022-01-01) -
Endocrine mucin-producing sweat gland carcinoma of the eyelid – A diagnostic challenge
by: Viral M. Bhanvadia, et al.
Published: (2024-04-01) -
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
by: Kenichi Kimoto, et al.
Published: (2012-01-01)